Dr. Ing. h.c. F. Porsche AG (DRPRY) Fair Value & Analysis
Consumer Cyclical · US · Market cap $50.0B
Dr. Ing. h.c. F. Porsche AG
DRPRY · US
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 6 days ago
Fair value updated Jun 24, 2026 — revised from $0.9000 to $1.18 (+31.1%) since Jun 23, 2026. Share price −7.6% over the past month.
Price vs Fair Value (12 months)
12‑month range $4.42 – $6.16 · fair‑value band $0.8900 – $1.48 · the $5.34 price screens above the $1.18 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Dr. Ing. h.c. F. Porsche AG (DRPRY) currently trades at $5.34, while our model-based Fair Value estimate is $1.18 — implying the stock looks roughly 77.9% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Dr. Ing. h.c. F. Porsche AG generated revenue of $35.8B at a net margin of 0.9%. Revenue declined 5.2% year over year. It earns a return on equity of 0.8%. Net debt stands at $6.4B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as related services. It also offers leasing, dealer and customer financing, mobility services for Porsche brand vehicles, and other finance-related services. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG is a subsidiary of Porsche Holding Stuttgart GmbH.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dr. Ing. h.c. F. Porsche AG reported revenue of $36.3B in FY2025 versus $33.1B in FY2021, a compound +2.3%/yr. Reported net income was $431M in FY2025, compounding −42.8%/yr from FY2021.
Open the full interactive analysis →
Recent news
- For superfans of luxury brands from Porsche to Fendi, there's a condo for that
- Volkswagen to cut up to 100,000 jobs globally
- Ford CEO on JD Power win: This 'overnight success' was actually 4 years in the making
- Porsche Looks to Reduce Complexity by Cutting Models
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Auto Manufacturers stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Mahindra & Mahindra Limited MHID | $0.3205 | $0.6300 | +97% |
| Toyota Motor Corporation TM | $169.73 | $201.26 | +19% |
| VOW3 VOW3 | €87.66 | €102.86 | +17% |
| BYD Company 002594 | ¥93.01 | ¥40.25 | -57% |
| Tesla, Inc TSLA | 39,580 ARS | 29,518 ARS | -25% |
| Hyundai Motor Company 005380 | 602,000 KRW | 478,385 KRW | -21% |
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Dr. Ing. h.c. F. Porsche AG (DRPRY) undervalued?
What is the fair value of DRPRY?
What is the quality score of DRPRY?
What is the revenue of Dr. Ing. h.c. F. Porsche AG (DRPRY)?
What is the net profit margin of DRPRY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.